share_log

Bluejay Diagnostics Announces 1-For-50 Reverse Stock Split, Will Open For Trading On The Nasdaq Capital Market On A Post-Split Basis On November 18, 2024

ブルージェイ・ダイアグノスティクスは、1対50の逆株式分割を発表し、2024年11月18日にナスダック資本市場で分割後に取引を開始します。

Benzinga ·  11/13 17:11

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) ("Bluejay" or the "Company"), a medical technology company developing rapid diagnostics on its Symphony platform to improve patient outcomes in critical care settings, today announced that the Company's Board of Directors has approved a reverse stock split of its shares of common stock at a ratio of 1-for-50 (the "Reverse Stock Split"). The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on November 18, 2024, and the Company's common stock will open for trading on The Nasdaq Capital Market on a post-split basis on November 18, 2024 under the Company's existing trading symbol, "BJDX." At such time, the Company's common stock will also commence trading with a new CUSIP number, 095633509.

これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報
    コメントする